Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty
Phase 4
Completed
- Conditions
- Diabetes Mellitus, Type 2Coronary Restenosis
- Registration Number
- NCT00162357
- Lead Sponsor
- Lantheus Medical Imaging
- Brief Summary
The purpose of this clinical research study is determine if patients with diabetes that have undergone previous opening of a heart blockage may have a blockage that is not causing any symptoms that may be detected by imaging with Cardiolite.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 106
Inclusion Criteria
- Type II Diabetes on medication & angioplasty within the past 6 months.
Exclusion Criteria
- Myocardial infarction or repeat angioplasty with the past 5 months.
- Unable to perform exercise or pharmacologic stress test.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Evaluate symptom-free heart blockages that develop following initial opening in patients with Type II diabetes mellitus based on Cardiolite imaging
- Secondary Outcome Measures
Name Time Method Determine how often symptom-free heart blockages occur 5-6 months after opening in patients with Type II diabetes mellitus Examine the relative value of ejection fraction, summed stress, rest, and difference MPI scores for identifying patients with cardiac events during 18 month follow-up. Compare patient hospital and out-patient cost for cardiac care for each group of patients (MPI versus standard care).
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie asymptomatic restenosis detection in diabetic patients post-PCI using Cardiolite stress MPI?
How does Cardiolite stress MPI compare to standard-of-care imaging for detecting coronary restenosis in type 2 diabetes patients?
Which biomarkers correlate with asymptomatic restenosis risk in type 2 diabetes patients following percutaneous coronary intervention?
What adverse events are associated with Cardiolite stress MPI in post-PCI diabetic patients and how are they managed?
Are there alternative radiopharmaceuticals to Cardiolite for MPI in diabetic patients with prior coronary interventions?
Trial Locations
- Locations (1)
Local Institution
🇵🇷San Juan, Puerto Rico
Local Institution🇵🇷San Juan, Puerto Rico